Spinocerebellar Ataxias Clinical Trial
Official title:
Integrative Medicine and Tai-chi in Clinical Status of Spinocerebellar Ataxia
NCT number | NCT03687190 |
Other study ID # | 121013 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 13, 2013 |
Est. completion date | December 2, 2015 |
Verified date | August 2023 |
Source | Changhua Christian Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Spinocerebellar atrophy is the most common autosomal dominant inherited ataxia. There are over thirty subtypes, which characterize neurologic features differently. They all have obvious substantial cerebellar atrophies in image, and unstable gait、ataxia. In general a prevalence of about three cases per 100 000 people is assumed, but this may be an underestimate. Progressive neurologic degeneration, in about 10-20 years, will leads to disability or wheelchair-dependent. Accompanying with fatigue, downhill course of the disease often made patients depressive and hopeless. The recent review of researches concludes no effective therapy for the disease. The purpose of the investigator's study is to explore the Tai-chi exercise effect for spinocerebellar ataxia.
Status | Completed |
Enrollment | 21 |
Est. completion date | December 2, 2015 |
Est. primary completion date | December 2, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility | Inclusion Criteria: - progressive ataxia accompanied with the observation of cerebellar atrophy on magnetic resonance or computed tomography images - SARA score of less than 20 Exclusion Criteria: - Patients with complicated cerebellar disorders, such as multiple system atrophy, Parkinson-plus syndromes, secondary cerebellar degeneration from encephalitis, trauma, hypoxia, cerebrovascular diseases, and toxic- or drug-induced cerebellar degeneration - SARA score of larger than 20 |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Changhua Christian Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Scale for the Assessment and Rating of Ataxia(SARA) | SARA assesses eight aspects of cerebellar function: walking, sitting, standing, speaking, finger chasing, the nose-finger test, fast alternating hand movements, and the heel-shin slide. The eight categories accumulate score ranging from 0 (no ataxia) to 40 (most severe ataxia).Gait (0-8 points),Stance (0-6 points),Sitting (0-4 points),Speech disturbance (0-6 points),Finger chase (0-4 points),Nose-finger test (0-4 points),Fast alternating hand movement (0-4 points),Heel-shin slide (0-4 points) | assessed at baseline and 9 months, 9 months reported as Outcome Measure Data |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05973019 -
rTMS Improves Functions in Spinocerebellar Ataxia
|
N/A | |
Completed |
NCT04837027 -
Effect of Training on Brain Volume in Ataxia
|
N/A | |
Completed |
NCT04595578 -
Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia
|
N/A | |
Completed |
NCT03745248 -
Aerobic Exercise, Balance Training, and Ataxia
|
N/A | |
Completed |
NCT05951010 -
Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38
|
N/A | |
Completed |
NCT01037777 -
RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
|
||
Completed |
NCT00136630 -
Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
|
||
Active, not recruiting |
NCT03701399 -
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
|
Phase 3 | |
Completed |
NCT05436262 -
Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia
|
N/A | |
Recruiting |
NCT04231487 -
Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
|
||
Withdrawn |
NCT04301284 -
Study of CAD-1883 for Spinocerebellar Ataxia
|
Phase 2 | |
Not yet recruiting |
NCT06397274 -
Stemchymal® for Polyglutamine Spinocerebellar Ataxia
|
Phase 2 | |
Not yet recruiting |
NCT06177626 -
Impact of Exercise on Eyeblink Conditioning in Spinocerebellar Ataxias
|
N/A | |
Recruiting |
NCT04529252 -
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
|
||
Completed |
NCT05621200 -
Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia
|
N/A | |
Completed |
NCT03701776 -
Ataxia and Exercise Disease Using MRI and Gait Analysis
|
N/A | |
Completed |
NCT03120013 -
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia
|
N/A | |
Active, not recruiting |
NCT03408080 -
Open Pilot Trial of BHV-4157
|
Phase 3 | |
Active, not recruiting |
NCT02960893 -
Trial in Adult Subjects With Spinocerebellar Ataxia
|
Phase 2/Phase 3 | |
Completed |
NCT04153110 -
Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia
|
N/A |